Interferon-gamma in the first-line therapy of ovarian cancer: a randomized phase III trial

This publication has 24 references indexed in Scilit:

• CELLULAR RESPONSES TO INTERFERON-γ
  Annual Review of Immunology, 1997
• Cyclophosphamide and Cisplatin Compared with Paclitaxel and Cisplatin in Patients with Stage III and Stage IV Ovarian Cancer
  New England Journal of Medicine, 1996
• Interferon-γ: Biology and Role in Pathogenesis
  Published by Elsevier ,1996
• Modulation of cisplatin cytotoxicity by human recombinant interferon-γ in human ovarian cancer cell lines
  European Journal Of Cancer, 1994
• Enhanced in vivo growth and resistance to rejection of tumor cells expressing dominant negative IFNγ receptors
  Immunity, 1994
• Anti‐tumor and immunomodulatory activity of intraperitoneal IFN‐γ in ovarian carcinoma patients with minimal residual tumor after chemotherapy
  International Journal of Cancer, 1992
• Effect of Prior Cancer Chemotherapy on Human Tumor-Specific Cytotoxicity In Vitro in Response to Immunopotentiating Biologic Response Modifiers
  JNCI Journal of the National Cancer Institute, 1991
• A Phase II Study of the Efficacy of Recombinant Interferon Gamma in Relapsing Ovarian Adenocarcinoma
  American Journal of Clinical Oncology, 1988
• Interferon-γ for the treatment of metastatic renal cancer: Dose-dependent stimulation and downregulation of beta2 microglobulin and neopterin responses
  Immunobiology, 1987
• Interferon-γ is required in activation of macrophages for tumor cytotoxicity
  Cellular Immunology, 1983